[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-334328-en":59,"doc-seo-334328-105":81},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":4},334328,1099514068365,"Aurelia","https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives - Review","Cancer immunotherapy harnesses the body’s immune system to counter malignancies and represents a major therapeutic advance. This review follows its development from late-19th-century pioneering concepts, including immune activation through bacterial toxins, to modern modalities. Key eras include cytokine-based approaches, the emergence of immune checkpoint biology, and the breakthrough impact of CAR-T cell therapy. It also discusses the rationale and ongoing optimization of cancer vaccines, concluding that continued study of immune complexity will further strengthen oncology outcomes worldwide.","Korean Journal of Clinical Oncology 2024;20:51-73 [https://doi.org/10.14216/kjco.24009](https://doi.org/10.14216/kjco.24009)[ ](https://doi.org/10.14216/kjco.24009)[pISSN 1738-8082](pISSN 1738-8082) ∙ eISSN 2288-4084  \nReview  \nThe evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives  \nSana Ahuja, Sufian Zaheer  \nDepartment of Pathology, Safdarjung Hospital, Vardhman Mahavir Medical College, New Delhi, India  \nCancer immunotherapy uses the body’s immune system to combat cancer, marking a significant advancement in treatment. This review traces its evolution from the late 19th century to its current status. It began with William Coley’s pioneering work using bacterial toxins to stimulate the immune system against cancer cells, establishing the foundational concept of immunotherapy. In the mid-20th century, cytokine therapies like interferons and interleukins emerged, demonstrating that altering the immune response could reduce tumors and highlighting the complex interplay between cancer and the immune system. The discovery of immune checkpoints, regulatory pathways that prevent autoimmunity but are exploited by cancer cells to evade detection, was a pivotal development. Another major breakthrough is CAR-T cell therapy, which involves modifying a patient’s T cells to target cancer-specific antigens. This personalized treatment has shown remarkable success in certain blood cancers. Additionally, cancer vaccines aim to trigger immune responses against tumor-specific or associated antigens, and while challenging, ongoing research is improving their efficacy. The historical progression of cancer immunotherapy, from Coley’s toxins to modern innovations like checkpoint inhibitors and CAR-T cell therapy, underscores its transformative impact on cancer treatment. As research delves deeper into the immune system’s complexities, immunotherapy is poised to become even more crucial in oncology, offering renewed hope to patients globally.  \nKeywords: Immunotherapy, Immune checkpoint inhibitors, Adoptive immunotherapy  \nINTRODUCTION  \nScientists have been honored with more than seventeen Nobel Prizes for their contributions to immunology and associated fields [1]. Cancer immunotherapy represents a groundbreaking approach in the field of oncology, revolutionizing how we combat various forms of cancer [2-4]. This innovative treatment method revolves around leveraging the body’s own immune system, our most potent defense mechanism, to combat malignant cells [5] . Unlike conventional cancer treatments like chemotherapy and radiation therapy, which can be accompanied by severe side effects  \nReceived: Aug 19, 2024 Revised: Oct 24, 2024 Accepted: Nov 19, 2024  \nCorrespondence to: Sufian Zaheer  \nDepartment of Pathology, Safdarjung Hospital, Vardhman Mahavir Medical College, Ansari Nagar, New Delhi 110029, India  \nTel: +91-9650594818, Fax: +91-9958188632  \n[E-mail:](E-mail: sufianzaheer@gmail.com)[ sufianzaheer@gmail.com](E-mail: sufianzaheer@gmail.com)[ ](E-mail: sufianzaheer@gmail.com)© 2024 Korean Society of Surgical Oncology  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0](http://creativecommons.org/licenses/by-nc/4.0)) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \ndue to their non-specific targeting, immunotherapy offers a more targeted and nuanced strategy [6].  \nAt its core, cancer immunotherapy aims to activate or enhance the body’s immune response against cancer cells [2,7] . This is achieved through a variety of mechanisms, includingthe administration of immune checkpoint inhibitors, adoptive cell transfer, cytokine therapy, and therapeutic cancer vaccines, among others [8- 10]. These approaches are designed to either stimulate the immune system or remove barriers that prevent it from","cbCaisA0BhXgQiaP","https://ap.wps.com/l/cbCaisA0BhXgQiaP","pdf",908371,23,"English","en",105,"# Introduction\n# The Foundation of Cancer Immunotherapy\n## Historical perspectives to current scenario","[{\"question\":\"What challenges and variability are noted for immunotherapy effectiveness?\",\"answer\":\"Immunotherapy remains evolving, with challenges such as differences in efficacy, response rates, resistance, and side effects. Outcomes can vary by cancer type and stage as well as individual patient characteristics.\"}]","The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives - Review | PDF",1790006279,58,{"code":4,"msg":82,"data":83},"ok",{"site_id":75,"language":74,"slug":84,"title":65,"keywords":85,"description":66,"schema_data":86,"social_meta":132,"head_meta":134,"extra_data":136,"updated_unix":137},"the-evolution-of-cancer-immunotherapy-a-comprehensive-review-of-its-history-and-current-perspectives-review","",{"@graph":87,"@context":131},[88,102,122],{"@type":89,"itemListElement":90},"BreadcrumbList",[91,95,97,100],{"item":92,"name":93,"@type":94,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":96,"name":9,"@type":94,"position":14},"https://docshare.wps.com/document/",{"item":98,"name":40,"@type":94,"position":99},"https://docshare.wps.com/document/research-report/",3,{"item":101,"name":65,"@type":94,"position":19},"https://docshare.wps.com/document/the-evolution-of-cancer-immunotherapy-a-comprehensive-review-of-its-history-and-current-perspectives-review/334328/",{"url":101,"name":65,"@type":103,"image":104,"author":109,"headline":65,"publisher":111,"fileFormat":114,"inLanguage":74,"description":66,"dateModified":115,"datePublished":116,"encodingFormat":114,"isAccessibleForFree":117,"interactionStatistic":118},"DigitalDocument",{"url":105,"@type":106,"width":107,"height":108},"https://docshare.wps.com/thumbnails/the-evolution-of-cancer-immunotherapy-a-comprehensive-review-of-its-history-and-current-perspectives-review/334328.png","ImageObject",300,407,{"name":63,"@type":110},"Person",{"url":92,"name":112,"@type":113},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":119,"interactionType":120,"userInteractionCount":39},"InteractionCounter",{"@type":121},"ViewAction",{"@type":123,"mainEntity":124},"FAQPage",[125],{"name":126,"@type":127,"acceptedAnswer":128},"What challenges and variability are noted for immunotherapy effectiveness?","Question",{"text":129,"@type":130},"Immunotherapy remains evolving, with challenges such as differences in efficacy, response rates, resistance, and side effects. Outcomes can vary by cancer type and stage as well as individual patient characteristics.","Answer","https://schema.org",{"og:url":101,"og:type":133,"og:title":65,"og:site_name":112,"og:description":66},"article",{"robots":135,"canonical":101},"index,follow",{"doc_id":61,"site_id":75},1790184747]